Chronic Migraine Headache
44
11
15
15
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
6.8%
3 terminated out of 44 trials
83.3%
-3.2% vs benchmark
14%
6 trials in Phase 3/4
27%
4 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (44)
Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine
Botulinum Toxin and/or Greater Occipital Nerve Block for Patients With Chronic Migraine
New Methods for Evaluating Preventive Migraine Treatment
Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for Pain Alleviation in Chronic Refractory Migraine.
Repeated Bilateral Greater Occipital Nerve Blockade in Chronic Migraine and Chronic Tension-Type Headache
Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study
Stellate Ganglion Blockade for Refractory Chronic Migraine
The Effect of Interventional Procedures on Serum CGRP and PACAP-38 Levels in Chronic Migraine
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Migraine
TCDS for the Treatment of Chronic Migraine
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Occipital Nerve Stimulation in Chronic Migraine
The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy
Occipital Blocks for Acute Migraine
Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID 12 and SQUID 18 in the Treatment of Patients With Chronic Resistant Migraine
A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine
Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine -
Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Efficacy of Nerve Block Versus Botox in Chronic Migraine Management